Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
Wyoming: below-average open trial sites
6 of 17 in-state trials are recruiting (35%); below the 37% national average by 2 percentage points.
According to ClinicalTrials.gov-derived indexes, Wyoming sits in the lower half of US states by in-state trial count (#51 of 52 states by registered in-state trial count).
Wyoming: 17 US clinical trials with in-state sites, 6 recruiting.
Wyoming has 17 registered US clinical trials with a study site in-state, 6 of them currently recruiting (below the 37% national average by 2 percentage points). 1 of these trials are in Phase 3 (late-stage) and 1 in Phase 2. The most frequently studied condition in Wyoming is Attention Deficit Hyperactivity Disorder, with 3 linked trials.
Thin-volume Wyoming archive
Wyoming lists 6 recruiting trials (p0 by absolute open slots). Treat this page as a compact local index (thin-volume · high-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.
Below-average open enrollment
Wyoming still shows 6 recruiting of 17 in-state trials (35% open), but below the 37% national average by 2 percentage points, so archived statuses weigh heavier than the national baseline.
- 35%
- open (below national share)
- 6
- still recruiting despite cool share
- 1
- Phase 2 rows in this footprint
- 3
- top: Attention Deficit Hyperactivity Disorder
Recruiting share is below the 37% national average by 2 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
Wyoming vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
17 Top 98% more indexed trials than 2% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for Wyoming on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Wyoming open-enrollment share matches the national baseline.
6 of 17 in-state trials (35.3%) are recruiting, against 37% nationally (-1.7 percentage points). Counts include every study with at least one recorded site in the state.
-
Laramie dominates Wyoming's trial geography.
Laramie lists 14 of 17 in-state trials (82.4%) across 3 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Attention Deficit Hyperactivity Disorder is the most-studied condition in Wyoming.
3 of 17 in-state trials (17.6%) list Attention Deficit Hyperactivity Disorder. That is a local concentration figure, not a national disease ranking.
-
One sponsor accounts for a large share of Wyoming trials.
University of Wyoming appears on 7 of 17 in-state trials (41.2%). Sponsor identity is as filed on ClinicalTrials.gov.
-
Most Wyoming indexed trials have already finished enrollment.
10 of 17 (58.8%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Completed | 10 |
| Recruiting | 6 |
| Active | 1 |
By Phase
| Phase | Trial count |
|---|---|
| NA | 12 |
| Phase 3 | 1 |
| Phase 2 | 1 |
Top Conditions
Top Sponsors
Where trials run in Wyoming
Laramie is the only Wyoming city with five or more listed trials, carrying 14 of the state's 17 across 3 named sites.
| City | Trials | Listed sites |
|---|---|---|
| Laramie | 14 | 3 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Recruiting-slot low
Wyoming lists 6 recruiting trials (p0 by absolute open slots).
Wyoming: absolute recruiting slots sit thin among states
Sites cluster almost entirely in Laramie: 14 of Wyoming's 17 indexed trials list a site there, across 3 named locations, and no other city reaches five.
Phase mix: 1 Phase 3 vs 1 Phase 2 (balanced across stages).
Top condition: Attention Deficit Hyperactivity Disorder (3 trials); top sponsor University of Wyoming (7).
thin-volume · high-open figures (17 trials · 35% open) describe registry geography under the recruiting-slot low read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near Wyoming on absolute recruiting slots
Cross-state peers under the recruiting-slot low read (thin-volume · high-open), not the same-state browse list.
Similar thin-volume peers (± open share)
- Puerto Rico · 14 trials · 57% recruiting
- Vermont · 191 trials · 31% recruiting
- North Dakota · 235 trials · 19% recruiting
- Montana · 250 trials · 22% recruiting
- South Dakota · 273 trials · 31% recruiting
Similar high-open peers (± trial volume)
- Ohio · 35% recruiting · 6,514 trials
- Massachusetts · 35% recruiting · 7,667 trials
- New York · 35% recruiting · 10,554 trials
- South Carolina · 35% recruiting · 1,706 trials
- Michigan · 34% recruiting · 4,790 trials